With the aim to characterize the role of PPAR-α in VB-mediated anti-inflammatory activity, we tested the efficacy of VB in an experimental model of inflammatory bowel disease induced by DNBS, comparing PPAR-αKO and WT mice. Here, PPARA is linked to inflammatory bowel disease.